Drug Shortage Report for HAVRIX 1440

Last updated on 2018-05-02 History
Report ID 44310
Drug Identification Number 02187078
Brand name HAVRIX - SUS IM 1440 ELISA UNITS/ML
Common or Proper name hepatitis A vaccine, inactivated
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 1440UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's (vial / fiole)
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-04-11
Estimated end date 2018-05-04
Actual end date 2018-05-01
Shortage status Resolved
Updated date 2018-05-02
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2018-05-02 French Compare
v10 2018-05-02 English Compare
v9 2018-04-25 French Compare
v8 2018-04-25 English Compare
v7 2018-04-12 English Compare
v6 2018-04-11 French Compare
v5 2018-04-11 English Compare
v4 2018-04-04 French Compare
v3 2018-04-04 English Compare
v2 2018-03-29 French Compare
v1 2018-03-29 English Compare

Showing 1 to 11 of 11